Fig. 2
From: Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy
EFS between patients with BPFT mutation and wild type: after the 2nd and 4th chemotherapy, the tumor volume reduced and the BPTF gene mutation rate decreased accordingly. Patients with BPTF mutation may have a worse prognosis compared with patients with wild type, but the difference is not significant (P = 0.352)